The OTC Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global OTC Medicine size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global OTC Medicine market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
OTC Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gastrointestinal Tract
Dermatology
Otolaryngology
Nutrition/Vitamins
Others
Market segment by Application, can be divided into
Pharmacy
Hospital Pharmacy
Online Retailer
Others
Market segment by players, this report covers
Procter & Gamble
Johnson & Johnson
GlaxoSmithKline Plc
Abbott Laboratories
Amway Corporation
Bayer
Aktienge
Sanofi
Pfizer
Reckitt Benckiser Group
Church & Dwight
Bayer HealthCare
AstraZeneca
BioGaia
Bristol Myers Squibb
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe OTC Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of OTC Medicine, with revenue, gross margin and global market share of OTC Medicine from 2019 to 2021.
Chapter 3, the OTC Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and OTC Medicine market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe OTC Medicine research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of OTC Medicine
1.2 Classification of OTC Medicine by Type
1.2.1 Overview: Global OTC Medicine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global OTC Medicine Revenue Market Share by Type in 2020
1.2.3 Gastrointestinal Tract
1.2.4 Dermatology
1.2.5 Otolaryngology
1.2.6 Nutrition/Vitamins
1.2.7 Others
1.3 Global OTC Medicine Market by Application
1.3.1 Overview: Global OTC Medicine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Online Retailer
1.3.5 Others
1.4 Global OTC Medicine Market Size & Forecast
1.5 Global OTC Medicine Market Size and Forecast by Region
1.5.1 Global OTC Medicine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global OTC Medicine Market Size by Region, (2016-2021)
1.5.3 North America OTC Medicine Market Size and Prospect (2016-2026)
1.5.4 Europe OTC Medicine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific OTC Medicine Market Size and Prospect (2016-2026)
1.5.6 South America OTC Medicine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa OTC Medicine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 OTC Medicine Market Drivers
1.6.2 OTC Medicine Market Restraints
1.6.3 OTC Medicine Trends Analysis
2 Company Profiles
2.1 Procter & Gamble
2.1.1 Procter & Gamble Details
2.1.2 Procter & Gamble Major Business
2.1.3 Procter & Gamble OTC Medicine Product and Solutions
2.1.4 Procter & Gamble OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Procter & Gamble Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson OTC Medicine Product and Solutions
2.2.4 Johnson & Johnson OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business
2.3.3 GlaxoSmithKline Plc OTC Medicine Product and Solutions
2.3.4 GlaxoSmithKline Plc OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline Plc Recent Developments and Future Plans
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business
2.4.3 Abbott Laboratories OTC Medicine Product and Solutions
2.4.4 Abbott Laboratories OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Abbott Laboratories Recent Developments and Future Plans
2.5 Amway Corporation
2.5.1 Amway Corporation Details
2.5.2 Amway Corporation Major Business
2.5.3 Amway Corporation OTC Medicine Product and Solutions
2.5.4 Amway Corporation OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Amway Corporation Recent Developments and Future Plans
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer OTC Medicine Product and Solutions
2.6.4 Bayer OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bayer Recent Developments and Future Plans
2.7 Aktienge
2.7.1 Aktienge Details
2.7.2 Aktienge Major Business
2.7.3 Aktienge OTC Medicine Product and Solutions
2.7.4 Aktienge OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Aktienge Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi OTC Medicine Product and Solutions
2.8.4 Sanofi OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer OTC Medicine Product and Solutions
2.9.4 Pfizer OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Reckitt Benckiser Group
2.10.1 Reckitt Benckiser Group Details
2.10.2 Reckitt Benckiser Group Major Business
2.10.3 Reckitt Benckiser Group OTC Medicine Product and Solutions
2.10.4 Reckitt Benckiser Group OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Reckitt Benckiser Group Recent Developments and Future Plans
2.11 Church & Dwight
2.11.1 Church & Dwight Details
2.11.2 Church & Dwight Major Business
2.11.3 Church & Dwight OTC Medicine Product and Solutions
2.11.4 Church & Dwight OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Church & Dwight Recent Developments and Future Plans
2.12 Bayer HealthCare
2.12.1 Bayer HealthCare Details
2.12.2 Bayer HealthCare Major Business
2.12.3 Bayer HealthCare OTC Medicine Product and Solutions
2.12.4 Bayer HealthCare OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Bayer HealthCare Recent Developments and Future Plans
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca OTC Medicine Product and Solutions
2.13.4 AstraZeneca OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 AstraZeneca Recent Developments and Future Plans
2.14 BioGaia
2.14.1 BioGaia Details
2.14.2 BioGaia Major Business
2.14.3 BioGaia OTC Medicine Product and Solutions
2.14.4 BioGaia OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 BioGaia Recent Developments and Future Plans
2.15 Bristol Myers Squibb
2.15.1 Bristol Myers Squibb Details
2.15.2 Bristol Myers Squibb Major Business
2.15.3 Bristol Myers Squibb OTC Medicine Product and Solutions
2.15.4 Bristol Myers Squibb OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Bristol Myers Squibb Recent Developments and Future Plans
2.16 Chr. Hansen
2.16.1 Chr. Hansen Details
2.16.2 Chr. Hansen Major Business
2.16.3 Chr. Hansen OTC Medicine Product and Solutions
2.16.4 Chr. Hansen OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Chr. Hansen Recent Developments and Future Plans
2.17 Cipla
2.17.1 Cipla Details
2.17.2 Cipla Major Business
2.17.3 Cipla OTC Medicine Product and Solutions
2.17.4 Cipla OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Cipla Recent Developments and Future Plans
2.18 CoLucid
2.18.1 CoLucid Details
2.18.2 CoLucid Major Business
2.18.3 CoLucid OTC Medicine Product and Solutions
2.18.4 CoLucid OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 CoLucid Recent Developments and Future Plans
2.19 Daiichi Sankyo
2.19.1 Daiichi Sankyo Details
2.19.2 Daiichi Sankyo Major Business
2.19.3 Daiichi Sankyo OTC Medicine Product and Solutions
2.19.4 Daiichi Sankyo OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Daiichi Sankyo Recent Developments and Future Plans
2.20 Friggs
2.20.1 Friggs Details
2.20.2 Friggs Major Business
2.20.3 Friggs OTC Medicine Product and Solutions
2.20.4 Friggs OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Friggs Recent Developments and Future Plans
2.21 DSM
2.21.1 DSM Details
2.21.2 DSM Major Business
2.21.3 DSM OTC Medicine Product and Solutions
2.21.4 DSM OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 DSM Recent Developments and Future Plans
2.22 Eisai
2.22.1 Eisai Details
2.22.2 Eisai Major Business
2.22.3 Eisai OTC Medicine Product and Solutions
2.22.4 Eisai OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Eisai Recent Developments and Future Plans
2.23 Eli Lilly
2.23.1 Eli Lilly Details
2.23.2 Eli Lilly Major Business
2.23.3 Eli Lilly OTC Medicine Product and Solutions
2.23.4 Eli Lilly OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.23.5 Eli Lilly Recent Developments and Future Plans
2.24 Herbalife
2.24.1 Herbalife Details
2.24.2 Herbalife Major Business
2.24.3 Herbalife OTC Medicine Product and Solutions
2.24.4 Herbalife OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.24.5 Herbalife Recent Developments and Future Plans
2.25 Euradite
2.25.1 Euradite Details
2.25.2 Euradite Major Business
2.25.3 Euradite OTC Medicine Product and Solutions
2.25.4 Euradite OTC Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.25.5 Euradite Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global OTC Medicine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 OTC Medicine Players Market Share
3.2.2 Top 10 OTC Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 OTC Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global OTC Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global OTC Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global OTC Medicine Revenue Market Share by Application (2016-2021)
5.2 OTC Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America OTC Medicine Revenue by Type (2016-2026)
6.2 North America OTC Medicine Revenue by Application (2016-2026)
6.3 North America OTC Medicine Market Size by Country
6.3.1 North America OTC Medicine Revenue by Country (2016-2026)
6.3.2 United States OTC Medicine Market Size and Forecast (2016-2026)
6.3.3 Canada OTC Medicine Market Size and Forecast (2016-2026)
6.3.4 Mexico OTC Medicine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe OTC Medicine Revenue by Type (2016-2026)
7.2 Europe OTC Medicine Revenue by Application (2016-2026)
7.3 Europe OTC Medicine Market Size by Country
7.3.1 Europe OTC Medicine Revenue by Country (2016-2026)
7.3.2 Germany OTC Medicine Market Size and Forecast (2016-2026)
7.3.3 France OTC Medicine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom OTC Medicine Market Size and Forecast (2016-2026)
7.3.5 Russia OTC Medicine Market Size and Forecast (2016-2026)
7.3.6 Italy OTC Medicine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific OTC Medicine Revenue by Type (2016-2026)
8.2 Asia-Pacific OTC Medicine Revenue by Application (2016-2026)
8.3 Asia-Pacific OTC Medicine Market Size by Region
8.3.1 Asia-Pacific OTC Medicine Revenue by Region (2016-2026)
8.3.2 China OTC Medicine Market Size and Forecast (2016-2026)
8.3.3 Japan OTC Medicine Market Size and Forecast (2016-2026)
8.3.4 South Korea OTC Medicine Market Size and Forecast (2016-2026)
8.3.5 India OTC Medicine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia OTC Medicine Market Size and Forecast (2016-2026)
8.3.7 Australia OTC Medicine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America OTC Medicine Revenue by Type (2016-2026)
9.2 South America OTC Medicine Revenue by Application (2016-2026)
9.3 South America OTC Medicine Market Size by Country
9.3.1 South America OTC Medicine Revenue by Country (2016-2026)
9.3.2 Brazil OTC Medicine Market Size and Forecast (2016-2026)
9.3.3 Argentina OTC Medicine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa OTC Medicine Revenue by Type (2016-2026)
10.2 Middle East & Africa OTC Medicine Revenue by Application (2016-2026)
10.3 Middle East & Africa OTC Medicine Market Size by Country
10.3.1 Middle East & Africa OTC Medicine Revenue by Country (2016-2026)
10.3.2 Turkey OTC Medicine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia OTC Medicine Market Size and Forecast (2016-2026)
10.3.4 UAE OTC Medicine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global OTC Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global OTC Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market OTC Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global OTC Medicine Revenue (USD Million) by Region (2016-2021)
Table 5. Global OTC Medicine Revenue Market Share by Region (2021-2026)
Table 6. Procter & Gamble Corporate Information, Head Office, and Major Competitors
Table 7. Procter & Gamble Major Business
Table 8. Procter & Gamble OTC Medicine Product and Solutions
Table 9. Procter & Gamble OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson OTC Medicine Product and Solutions
Table 13. Johnson & Johnson OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Plc Major Business
Table 16. GlaxoSmithKline Plc OTC Medicine Product and Solutions
Table 17. GlaxoSmithKline Plc OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Abbott Laboratories Major Business
Table 20. Abbott Laboratories OTC Medicine Product and Solutions
Table 21. Abbott Laboratories OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Amway Corporation Corporate Information, Head Office, and Major Competitors
Table 23. Amway Corporation Major Business
Table 24. Amway Corporation OTC Medicine Product and Solutions
Table 25. Amway Corporation OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bayer Corporate Information, Head Office, and Major Competitors
Table 27. Bayer Major Business
Table 28. Bayer OTC Medicine Product and Solutions
Table 29. Bayer OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Aktienge Corporate Information, Head Office, and Major Competitors
Table 31. Aktienge Major Business
Table 32. Aktienge OTC Medicine Product and Solutions
Table 33. Aktienge OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi OTC Medicine Product and Solutions
Table 37. Sanofi OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer OTC Medicine Product and Solutions
Table 41. Pfizer OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Reckitt Benckiser Group Corporate Information, Head Office, and Major Competitors
Table 43. Reckitt Benckiser Group Major Business
Table 44. Reckitt Benckiser Group OTC Medicine Product and Solutions
Table 45. Reckitt Benckiser Group OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Church & Dwight Corporate Information, Head Office, and Major Competitors
Table 47. Church & Dwight Major Business
Table 48. Church & Dwight OTC Medicine Product and Solutions
Table 49. Church & Dwight OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Bayer HealthCare Corporate Information, Head Office, and Major Competitors
Table 51. Bayer HealthCare Major Business
Table 52. Bayer HealthCare OTC Medicine Product and Solutions
Table 53. Bayer HealthCare OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 55. AstraZeneca Major Business
Table 56. AstraZeneca OTC Medicine Product and Solutions
Table 57. AstraZeneca OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. BioGaia Corporate Information, Head Office, and Major Competitors
Table 59. BioGaia Major Business
Table 60. BioGaia OTC Medicine Product and Solutions
Table 61. BioGaia OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 63. Bristol Myers Squibb Major Business
Table 64. Bristol Myers Squibb OTC Medicine Product and Solutions
Table 65. Bristol Myers Squibb OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Chr. Hansen Corporate Information, Head Office, and Major Competitors
Table 67. Chr. Hansen Major Business
Table 68. Chr. Hansen OTC Medicine Product and Solutions
Table 69. Chr. Hansen OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Cipla Corporate Information, Head Office, and Major Competitors
Table 71. Cipla Major Business
Table 72. Cipla OTC Medicine Product and Solutions
Table 73. Cipla OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. CoLucid Corporate Information, Head Office, and Major Competitors
Table 75. CoLucid Major Business
Table 76. CoLucid OTC Medicine Product and Solutions
Table 77. CoLucid OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 79. Daiichi Sankyo Major Business
Table 80. Daiichi Sankyo OTC Medicine Product and Solutions
Table 81. Daiichi Sankyo OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Friggs Corporate Information, Head Office, and Major Competitors
Table 83. Friggs Major Business
Table 84. Friggs OTC Medicine Product and Solutions
Table 85. Friggs OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. DSM Corporate Information, Head Office, and Major Competitors
Table 87. DSM Major Business
Table 88. DSM OTC Medicine Product and Solutions
Table 89. DSM OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Eisai Corporate Information, Head Office, and Major Competitors
Table 91. Eisai Major Business
Table 92. Eisai OTC Medicine Product and Solutions
Table 93. Eisai OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 95. Eli Lilly Major Business
Table 96. Eli Lilly OTC Medicine Product and Solutions
Table 97. Eli Lilly OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 98. Herbalife Corporate Information, Head Office, and Major Competitors
Table 99. Herbalife Major Business
Table 100. Herbalife OTC Medicine Product and Solutions
Table 101. Herbalife OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 102. Euradite Corporate Information, Head Office, and Major Competitors
Table 103. Euradite Major Business
Table 104. Euradite OTC Medicine Product and Solutions
Table 105. Euradite OTC Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 106. Global OTC Medicine Revenue (USD Million) by Players (2019-2021)
Table 107. Global OTC Medicine Revenue Share by Players (2019-2021)
Table 108. Breakdown of OTC Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 109. OTC Medicine Players Head Office, Products and Services Provided
Table 110. OTC Medicine Mergers & Acquisitions in the Past Five Years
Table 111. OTC Medicine New Entrants and Expansion Plans
Table 112. Global OTC Medicine Revenue (USD Million) by Type (2016-2021)
Table 113. Global OTC Medicine Revenue Share by Type (2016-2021)
Table 114. Global OTC Medicine Revenue Forecast by Type (2021-2026)
Table 115. Global OTC Medicine Revenue by Application (2016-2021)
Table 116. Global OTC Medicine Revenue Forecast by Application (2021-2026)
Table 117. North America OTC Medicine Revenue by Type (2016-2021) & (USD Million)
Table 118. North America OTC Medicine Revenue by Type (2021-2026) & (USD Million)
Table 119. North America OTC Medicine Revenue by Application (2016-2021) & (USD Million)
Table 120. North America OTC Medicine Revenue by Application (2021-2026) & (USD Million)
Table 121. North America OTC Medicine Revenue by Country (2016-2021) & (USD Million)
Table 122. North America OTC Medicine Revenue by Country (2021-2026) & (USD Million)
Table 123. Europe OTC Medicine Revenue by Type (2016-2021) & (USD Million)
Table 124. Europe OTC Medicine Revenue by Type (2021-2026) & (USD Million)
Table 125. Europe OTC Medicine Revenue by Application (2016-2021) & (USD Million)
Table 126. Europe OTC Medicine Revenue by Application (2021-2026) & (USD Million)
Table 127. Europe OTC Medicine Revenue by Country (2016-2021) & (USD Million)
Table 128. Europe OTC Medicine Revenue by Country (2021-2026) & (USD Million)
Table 129. Asia-Pacific OTC Medicine Revenue by Type (2016-2021) & (USD Million)
Table 130. Asia-Pacific OTC Medicine Revenue by Type (2021-2026) & (USD Million)
Table 131. Asia-Pacific OTC Medicine Revenue by Application (2016-2021) & (USD Million)
Table 132. Asia-Pacific OTC Medicine Revenue by Application (2021-2026) & (USD Million)
Table 133. Asia-Pacific OTC Medicine Revenue by Region (2016-2021) & (USD Million)
Table 134. Asia-Pacific OTC Medicine Revenue by Region (2021-2026) & (USD Million)
Table 135. South America OTC Medicine Revenue by Type (2016-2021) & (USD Million)
Table 136. South America OTC Medicine Revenue by Type (2021-2026) & (USD Million)
Table 137. South America OTC Medicine Revenue by Application (2016-2021) & (USD Million)
Table 138. South America OTC Medicine Revenue by Application (2021-2026) & (USD Million)
Table 139. South America OTC Medicine Revenue by Country (2016-2021) & (USD Million)
Table 140. South America OTC Medicine Revenue by Country (2021-2026) & (USD Million)
Table 141. Middle East & Africa OTC Medicine Revenue by Type (2016-2021) & (USD Million)
Table 142. Middle East & Africa OTC Medicine Revenue by Type (2021-2026) & (USD Million)
Table 143. Middle East & Africa OTC Medicine Revenue by Application (2016-2021) & (USD Million)
Table 144. Middle East & Africa OTC Medicine Revenue by Application (2021-2026) & (USD Million)
Table 145. Middle East & Africa OTC Medicine Revenue by Country (2016-2021) & (USD Million)
Table 146. Middle East & Africa OTC Medicine Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. OTC Medicine Picture
Figure 2. Global OTC Medicine Revenue Market Share by Type in 2020
Figure 3. Gastrointestinal Tract
Figure 4. Dermatology
Figure 5. Otolaryngology
Figure 6. Nutrition/Vitamins
Figure 7. Others
Figure 8. OTC Medicine Revenue Market Share by Application in 2020
Figure 9. Pharmacy Picture
Figure 10. Hospital Pharmacy Picture
Figure 11. Online Retailer Picture
Figure 12. Others Picture
Figure 13. Global OTC Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global OTC Medicine Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global OTC Medicine Revenue Market Share by Region (2016-2026)
Figure 16. Global OTC Medicine Revenue Market Share by Region in 2020
Figure 17. North America OTC Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe OTC Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific OTC Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America OTC Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa OTC Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. OTC Medicine Market Drivers
Figure 23. OTC Medicine Market Restraints
Figure 24. OTC Medicine Market Trends
Figure 25. Procter & Gamble Recent Developments and Future Plans
Figure 26. Johnson & Johnson Recent Developments and Future Plans
Figure 27. GlaxoSmithKline Plc Recent Developments and Future Plans
Figure 28. Abbott Laboratories Recent Developments and Future Plans
Figure 29. Amway Corporation Recent Developments and Future Plans
Figure 30. Bayer Recent Developments and Future Plans
Figure 31. Aktienge Recent Developments and Future Plans
Figure 32. Sanofi Recent Developments and Future Plans
Figure 33. Pfizer Recent Developments and Future Plans
Figure 34. Reckitt Benckiser Group Recent Developments and Future Plans
Figure 35. Church & Dwight Recent Developments and Future Plans
Figure 36. Bayer HealthCare Recent Developments and Future Plans
Figure 37. AstraZeneca Recent Developments and Future Plans
Figure 38. BioGaia Recent Developments and Future Plans
Figure 39. Bristol Myers Squibb Recent Developments and Future Plans
Figure 40. Chr. Hansen Recent Developments and Future Plans
Figure 41. Cipla Recent Developments and Future Plans
Figure 42. CoLucid Recent Developments and Future Plans
Figure 43. Daiichi Sankyo Recent Developments and Future Plans
Figure 44. Friggs Recent Developments and Future Plans
Figure 45. DSM Recent Developments and Future Plans
Figure 46. Eisai Recent Developments and Future Plans
Figure 47. Eli Lilly Recent Developments and Future Plans
Figure 48. Herbalife Recent Developments and Future Plans
Figure 49. Euradite Recent Developments and Future Plans
Figure 50. Global OTC Medicine Revenue Share by Players in 2020
Figure 51. OTC Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 52. Global Top 3 Players OTC Medicine Revenue Market Share in 2020
Figure 53. Global Top 10 Players OTC Medicine Revenue Market Share in 2020
Figure 54. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 55. Global OTC Medicine Revenue Share by Type in 2020
Figure 56. Global OTC Medicine Market Share Forecast by Type (2021-2026)
Figure 57. Global OTC Medicine Revenue Share by Application in 2020
Figure 58. Global OTC Medicine Market Share Forecast by Application (2021-2026)
Figure 59. North America OTC Medicine Sales Market Share by Type (2016-2026)
Figure 60. North America OTC Medicine Sales Market Share by Application (2016-2026)
Figure 61. North America OTC Medicine Revenue Market Share by Country (2016-2026)
Figure 62. United States OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Canada OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Mexico OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Europe OTC Medicine Sales Market Share by Type (2016-2026)
Figure 66. Europe OTC Medicine Sales Market Share by Application (2016-2026)
Figure 67. Europe OTC Medicine Revenue Market Share by Country (2016-2026)
Figure 68. Germany OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. France OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. United Kingdom OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Russia OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Italy OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Asia-Pacific OTC Medicine Sales Market Share by Type (2016-2026)
Figure 74. Asia-Pacific OTC Medicine Sales Market Share by Application (2016-2026)
Figure 75. Asia-Pacific OTC Medicine Revenue Market Share by Region (2016-2026)
Figure 76. China OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Japan OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Korea OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. India OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Southeast Asia OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Australia OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. South America OTC Medicine Sales Market Share by Type (2016-2026)
Figure 83. South America OTC Medicine Sales Market Share by Application (2016-2026)
Figure 84. South America OTC Medicine Revenue Market Share by Country (2016-2026)
Figure 85. Brazil OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Argentina OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Middle East and Africa OTC Medicine Sales Market Share by Type (2016-2026)
Figure 88. Middle East and Africa OTC Medicine Sales Market Share by Application (2016-2026)
Figure 89. Middle East and Africa OTC Medicine Revenue Market Share by Country (2016-2026)
Figure 90. Turkey OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 91. Saudi Arabia OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 92. UAE OTC Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 93. Methodology
Figure 94. Research Process and Data Source